News
SYK
334.91
+2.21%
7.23
Baron Health Care Fund Q1 2024 Shareholder Letter
Baron Health Care Fund advanced 8.92% in the quarter ended March 31, 2024. The Fund's performance was in line with the Russell 3000 Health Care Index and the S&P 500 Index. Investments in health care equipment, pharmaceuticals, and life sciences added the most value in the period.
Seeking Alpha · 20h ago
Analysts Forecast 10% Gains Ahead For VOOV
NASDAQ · 22h ago
Should You Pick Abbott Stock At $105 After An Upbeat Q1?
NASDAQ · 23h ago
Stryker’s Resilience Amidst Competitive Pressures Reinforces Buy Rating
TipRanks · 2d ago
Weekly Report: what happened at SYK last week (0415-0419)?
Weekly Report · 2d ago
THQ: Collecting A High Yield From Increased Medical Spending
Abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The healthcare sector has lagged behind the S&P500 for the past year. THQ trades at an attractive discount to its NAV. The fund is diversified across 11 different sub sectors of healthcare.
Seeking Alpha · 3d ago
SYK Quantitative Stock Analysis - Martin Zweig
NASDAQ · 3d ago
Stryker Currently Down Seven Consecutive Days, On Track for Longest Losing Streak Since September 2022 -- Data Talk
Stryker Corporation (SYK) is currently at $333.10, down $2.93 or 0.87%. Currently down eight of the past nine days. Down 7.14% from its all-time closing high of $358.71 on March 27, 2024.
Dow Jones · 5d ago
Stryker Corporation (NYSE:SYK) On An Uptrend: Could Fundamentals Be Driving The Stock?
Stryker's (NYSE:SYK) return on equity is 17%. Stryker has shrunk its net income by 3.8% over the past year. The company has a high Return on Equity of 17%, compared to the industry average of 11%. The company's expected earnings growth rate is expected to be higher than the industry. Check out the ROE of Strykers and how it compares to others.
Simply Wall St · 5d ago
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
Stryker has outperformed the market over the past 20 years by 2.32% on an annualized basis. The company has an average annual return of 9.99%. If an investor had bought $100 of SYK stock 20 years ago, it would be worth $675.76 today.
Benzinga · 6d ago
Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay
NASDAQ · 6d ago
Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)
TipRanks · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities. The blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth. The Dow Jones Industrial Average was up 0.13% at 37,783.35. UnitedHealth Group's quarterly results beat expectations.
Reuters · 04/16 17:52
Here's Why You Should Retain Charles River (CRL) Stock Now
NASDAQ · 04/16 15:50
BUZZ-Medical device makers fall after J&J's medtech unit misses sales estimates
Shares of medical device makers fall between 1% and 3% after Johnson & Johnson's JNJ.N medical devices unit reports Q1 sales of $7.82 bln. Analysts point to weakness in JNJ's vision care products and surgical devices. Stryker, Zimmer Biomet and Medtronic among those down.
Reuters · 04/16 15:25
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
NASDAQ · 04/16 14:56
SYK Quantitative Stock Analysis - Martin Zweig
NASDAQ · 04/16 14:07
UPDATE 5-J&J's medical device sales fall short, cancer drugs seen growing
J&J's medical device sales fall short, cancer drugs seen growing. Sales of psoriasis drug Stelara come in lower than expected. The company's large medical devices business reported $7.82 billion in sales for first quarter. J&J shares were down 1.3% in after-hours trading.
Reuters · 04/16 10:30
Stryker Is Maintained at Outperform by RBC Capital
Dow Jones · 04/15 18:32
Stryker Price Target Raised to $386.00/Share From $360.00 by RBC Capital
Dow Jones · 04/15 18:32
More
Webull provides a variety of real-time SYK stock news. You can receive the latest news about Stryker Corp through multiple platforms. This information may help you make smarter investment decisions.
About SYK
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. The Company operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Stryker's geographical segments include the United States and the International.